Kaplan-Meier survival analysis showed that IGSF10 expression was inversely correlated with survival outcomes of kidney chromophobe (KICH), sarcoma (SARC), lower grade glioma (LGG), uterine corpus endometrial carcinoma (UCEC), thymoma (THYM), and LUAD patients (Figure 4B–4H). This evidence concerns the gene IGSF10 and central nervous system cancer.